November 14, 2019
Article
For what other indications, and in what regimens, are investigators assessing the drug class?
November 13, 2019
Certain diet-based comorbid conditions are more prevalent in food-allergic patients.
November 12, 2019
At least 1 major food allergy trial in recent years has given allergists incentive to set detailed strategies for their patients.
Could the drug class best serve patients as an adjunctive, a monotherapy, or maybe a prophylaxis for symptoms?
November 11, 2019
Though research behind preventive measures is lacking, there are common steps that could be taken to reduce pediatric risk.
As new methods of treatment come to the market, allergists need to ensure their patients are fully informed and able to set their own goals for care.
November 10, 2019
Video
How can physicians train parents to trust immunotherapy—an allergen exposure they were previously told to avoid?
A growing patient population and burdens of physician shortage require specialists and primary care collaborate more and more.
Assessing a food allergy patient's overall diet during immunotherapy trials could unlock understanding how the microbiome affects the allergic reaction.
Distinguishing biologic-eligible patients may still need further biomarker and disease severity research.
